FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

paolo costantino

Research Profile

Chemicals & Drugs

Anatomy

Bacterial Capsules

Living Beings

Co-author Network

Publications

TOP 3
Carla Bromuro; Maria Romano; Paola Chiani; Francesco Berti; Marta Tontini; Daniela Proietti; Elena Mori; Antonella Torosantucci; paolo costantino; Rino Rappuoli; Antonio Cassone
Beta-glucan-CRM197 conjugates as candidates antifungal vaccines.
Angela Bardotti; Giovanni Averani; Francesco Berti; Stefania Berti; Valeria Carinci; Sandro D'Ascenzi; Barbara Fabbri; Sara Giannini; Aldo Giannozzi; Claudia Magagnoli; Daniela Proietti; Francesco Norelli; Rino Rappuoli; Stefano Ricci; paolo costantino
Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases.
Antonella Torosantucci; Carla Bromuro; Paola Chiani; Flavia De Bernardis; Francesco Berti; Chiara Galli; Francesco Norelli; Cinzia Bellucci; Luciano Polonelli; paolo costantino; Rino Rappuoli; Antonio Cassone
A novel glyco-conjugate vaccine against fungal pathogens.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of paolo costantino (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Carla Bromuro; Maria Romano; Paola Chiani; Francesco Berti; Marta Tontini; Daniela Proietti; Elena Mori; Antonella Torosantucci; paolo costantino; Rino Rappuoli; Antonio Cassone
Beta-glucan-CRM197 conjugates as candidates antifungal vaccines.
Vaccine 2010;28(14):2615-23.
2008: Angela Bardotti; Giovanni Averani; Francesco Berti; Stefania Berti; Valeria Carinci; Sandro D'Ascenzi; Barbara Fabbri; Sara Giannini; Aldo Giannozzi; Claudia Magagnoli; Daniela Proietti; Francesco Norelli; Rino Rappuoli; Stefano Ricci; paolo costantino
Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases.
Vaccine 2008;26(18):2284-96.
2005: Antonella Torosantucci; Carla Bromuro; Paola Chiani; Flavia De Bernardis; Francesco Berti; Chiara Galli; Francesco Norelli; Cinzia Bellucci; Luciano Polonelli; paolo costantino; Rino Rappuoli; Antonio Cassone
A novel glyco-conjugate vaccine against fungal pathogens.
The Journal of experimental medicine 2005;202(5):597-606.
2005: Johan Holst; Berit Feiring; Lisbeth M Naess; Gunnstein Norheim; Paul Kristiansen; E Arne Høiby; Klaus Bryn; Philipp Oster; paolo costantino; Muhamed-Kheir Taha; Jean-Michel Alonso; Dominique A Caugant; Elisabeth Wedege; Ingeborg S Aaberge; Rino Rappuoli; Einar Rosenqvist
The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.
Vaccine 2005;23(17-18):2202-5.
2004: Barbara C Baudner; Maurizio Morandi; Marzia M Giuliani; Jan Verhoef; Hans E Junginger; paolo costantino; Rino Rappuoli; Giuseppe Del Giudice
Modulation of immune response to group C meningococcal conjugate vaccine given intranasally to mice together with the LTK63 mucosal adjuvant and the trimethyl chitosan delivery system.
The Journal of infectious diseases 2004;189(5):828-32.
2004: Francesco Berti; paolo costantino; Marco Fragai; Claudio Luchinat
Water accessibility, aggregation, and motional features of polysaccharide-protein conjugate vaccines.
Biophysical journal 2004;86(1 Pt 1):3-9.
2002: Dirk J Lefeber; Ricardo Gutiérrez Gallego; Christian H Grün; Daniela Proietti; Sandro D'Ascenzi; paolo costantino; Johannis P Kamerling; Johannes Vliegenthart
Isolation of oligosaccharides from a partial-acid hydrolysate of pneumococcal type 3 polysaccharide for use in conjugate vaccines.
Carbohydrate research 2002;337(9):819-25.
2001: Fabiana Falugi; Roberto Petracca; Massimo Mariani; E Luzzi; Silvia Mancianti; V Carinci; M L Melli; Oretta Finco; Andreas Wack; A Di Tommaso; Maria Teresa De Magistris; paolo costantino; Giuseppe Del Giudice; Sergio Abrignani; Rino Rappuoli; Guido Grandi
Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines.
European journal of immunology 2001;31(12):3816-24.
2000: Neil Ravenscroft; Sandro D'Ascenzi; Daniela Proietti; Francesco Norelli; paolo costantino
Physicochemical characterisation of the oligosaccharide component of vaccines.
Developments in biologicals 2000;103():35-47.
2000: C Ceccarini; Mario Contorni; paolo costantino; Sandro D'Ascenzi; E Gallo; M Maffei; Donatella Mannucci; I Marsili; C Magagnoli; Samuele Peppoloni; Rino Rappuoli; Neil Ravenscroft; Stefano Ricci
Physicochemical characterisation of the pertussis vaccine.
Developments in biologicals 2000;103():175-88.
1999: Neil Ravenscroft; Giovanni Averani; Antonella Bartoloni; S Berti; M Bigio; V Carinci; paolo costantino; Sandro D'Ascenzi; Aldo Giannozzi; Francesco Norelli; C Pennatini; Daniela Proietti; C Ceccarini; P Cescutti
Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines.
Vaccine 1999;17(22):2802-16.
1999: paolo costantino; Francesco Norelli; Aldo Giannozzi; Sandro D'Ascenzi; Antonella Bartoloni; S Kaur; D Tang; R Seid; S Viti; R Paffetti; M Bigio; C Pennatini; Giovanni Averani; V Guarnieri; E Gallo; Neil Ravenscroft; C Lazzeroni; Rino Rappuoli; C Ceccarini
Size fractionation of bacterial capsular polysaccharides for their use in conjugate vaccines.
Vaccine 1999;17(9-10):1251-63.
1998: Massimo Mariani; E Luzzi; Daniela Proietti; Silvia Mancianti; D Casini; paolo costantino; Pieter van Gageldonk; Guy Berbers
A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b.
Clinical and diagnostic laboratory immunology 1998;5(5):667-74.
1995: Antonella Bartoloni; Francesco Norelli; C Ceccarini; Rino Rappuoli; paolo costantino
Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide.
Vaccine 1995;13(5):463-70.
1993: G Del Giudice; A Gervaix; paolo costantino; C A Wyler; Chantal Tougne; E R de Graeff-Meeder; J van Embden; R van der Zee; L Nencioni; R Rappuoli
Priming to heat shock proteins in infants vaccinated against pertussis.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(5):2025-32.
1993: M G Galli; Antonello Podda; paolo costantino; A Viti; L Aiello; F Ceratti; M Consonni
[Experience with anti-Haemophilus influenzae type B vaccination in children under 2 years of age].
Annali di igiene : medicina preventiva e di comunità 1993;5(2):91-5.
1992: C Barrios; A R Lussow; J Van Embden; R Van der Zee; R Rappuoli; paolo costantino; Jacques A Louis; Paul-Henri Lambert; G Del Giudice
Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming.
European journal of immunology 1992;22(6):1365-72.
1992: paolo costantino; S Viti; Antonello Podda; M A Velmonte; L Nencioni; Rino Rappuoli
Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C.
Vaccine 1992;10(10):691-8.
1992: A Sansoni; Rino Rappuoli; S Viti; paolo costantino; O Fanti; Carla Cellesi
Immunity to Haemophilus influenzae type b on sample population from central Italy.
Vaccine 1992;10(9):627-30.
1986: M Porro; paolo costantino; F Giovannoni; V Pellegrini; L Tagliaferri; F Vannozzi; S Viti
A molecular model of artificial glycoprotein with predetermined multiple immunodeterminants for gram-positive and gram-negative encapsulated bacteria.
Molecular immunology 1986;23(4):385-91.
1986: paolo costantino; S Viti; F Vannozzi; G Serafini; I Marsili; A Valeri
Immunochemistry of some bacterial oligosaccharide protein conjugates.
Annali Sclavo. Collana monografica 1986;3(1-2):359-66.
1985: M Porro; paolo costantino; S Viti; F Vannozzi; A Naggi; Giangiacomo Torri
Specific antibodies to diphtheria toxin and type 6A pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen.
Molecular immunology 1985;22(8):907-19.
1985: M Porro; paolo costantino; S Fabbiani; V Pellegrini; S Viti
A semi-synthetic glycoconjugate antigen prepared by chemical glycosilation of pertussis toxin by a meningococcal group C oligosaccharide hapten.
Developments in biological standardization 1985;61():525-30.